Greenrise Global Brands Inc.

XCX

CA39540L1085

Pharmaceuticals

Market Closed - Canadian Securities Exchange Other stock markets 10:35:35 2024-04-15 am EDT			5-day change	1st Jan Change
0.005 ^CAD	-66.67%		0.00%	-50.00%

2023	Greenrise Global Brands Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Greenrise Global Brands Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

Greenrise Global Brands Inc. Reports Earnings Results for the Full Year Ended December 31, 2022

July 07, 2023 at 02:45 pm EDT

Greenrise Global Brands Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was EUR 1.57 million compared to EUR 3.64 million a year ago. Basic loss per share was EUR 0.04 compared to EUR 0.12 a year ago.

Latest news about Greenrise Global Brands Inc.

Greenrise Global Brands Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 26	CI
Greenrise Global Brands Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-24	CI
Greenrise Global Brands Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-07-14	CI
Greenrise Global Brands Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-07-07	CI
Greenrise Global Brands Inc. Auditor Raises 'Going Concern' Doubt	23-07-06	CI
An unknown buyer acquired a 31% stake in CannaCare Health GmbH from Greenrise Global Brands Inc. for €0.3875 million.	23-03-09	CI
An unknown buyer acquired AMP Alternative Medical Products GmbH from Greenrise Global Brands Inc. for €0.59 million.	22-12-29	CI
Greenrise Global Brands Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-28	CI
An unknown buyer acquired 20% stake in CannaCare Health GmbH from Greenrise Global Brands Inc. for €0.25 million.	22-11-10	CI
Greenrise Global Brands Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-28	CI
Greenrise Global Brands Highlights Preliminary Sales for Q2; Developments regarding the Legislation of Adult-Use Cannabis in Germany	22-08-08	MT
Greenrise Global Brands Inc. Announces Unaudited Sales Results for the Second Quarter 2022	22-08-08	CI
Greenrise Global Brands Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-30	CI
Greenrise Global Brands Inc. Appoints Frank Otto to the Board of Directors	22-05-11	CI
Greenrise Global Brands Inc. Auditor Raises 'Going Concern' Doubt	22-05-05	CI
Greenrise Global Brands Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-05-05	CI
Greenrise Global Brands Inc. announced that it has received CAD 0.7234 million in funding	22-04-13	CI
Greenrise Global Jumped Near 20% From Near 52 Week Low Levels After Buying Majority Stake in CannaCare	22-04-05	MT
Greenrise Global Brands Up 16.7% after Reporting Purchase of Majority Stake in CannaCare Health	22-04-05	MT
Greenrise Global Brands Inc. to Appoint Frank Otto to its Board of Directors	22-04-05	CI
Greenrise Global Brands Inc. acquired 51% stake in CannaCare Health GmbH from its co-founders Frank Otto and the Oplesch family (CannaCare Shareholders) €3.02 million.	22-04-04	CI
Greenrise Global Brands Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-25	CI
Greenrise Global Brands Welcomes Germany's Legalization of Cannabis for Adults	21-11-25	MT
Greenrise Global Brands Inc. Launches Herbify CBD Wellness Brand in Germany	21-11-23	CI
Greenrise Global Brands Inc. announced that it expects to receive CAD 0.35 million in funding	21-11-21	CI

Chart Greenrise Global Brands Inc.

Duration

Period

More charts

Company Profile

Greenrise Global Brands Inc. is a Canada-based investment holding company with investments in the cannabis industry in Germany. The Company, through CannaCare Health GmbH (CannaCare), offers a range of approximately 20 cannabidiol (CBD) products consisting of tinctures, sprays and oils and skincare products made from natural raw materials manufactured in Europe and Germany and distributed through traditional sales channels, such as www.cannacare-health.com and www.canobo.de. CannaCare is a producer and supplier of CBD wellness products and wholly owns AMP Alternative Medical Products GmbH (AMP), an importer and distributor of European Union-Good Manufacturing Practice (EU-GMP) medical cannabis to pharmacies.

Sector

Pharmaceuticals

Calendar

2024-05-02 - Q4 2023 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
GREENRISE GLOBAL BRANDS INC.	-50.00%	173K
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-15.13%	4.51B
TASLY PHARMACEUTICAL GROUP CO., LTD	-9.75%	3.15B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+2.14%	3.1B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-6.82%	2.42B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+47.87%	1.97B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+0.09%	1.65B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-7.89%	1.68B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-12.97%	1.53B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+33.40%	1.38B